FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Veerhuis

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Immunohistochemistry

Co-author Network

Publications

TOP 3
Wesley Jongbloed; Maartje I Kester; Philip scheltens; Wiesje M van der Flier; Robert Veerhuis; Marinus A Blankenstein; Charlotte E Teunissen
Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study.
Maartje I Kester; Marleen J Koel-Simmelink; Peter G Scheffer; Philip scheltens; Charlotte E Teunissen; Harry Twaalfhoven; Jos W Twisk; Marinus A Blankenstein; Femke H Bouwman; Robert Veerhuis; Alie Schuitemaker; Wiesje M van der Flier
Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers.
Jeroen D C Goos; Philip scheltens; Charlotte E Teunissen; Frederik Barkhof; Marinus A Blankenstein; Robert Veerhuis; Nicolaas A Verwey; Wiesje M van der Flier
Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Veerhuis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Wesley Jongbloed; Maartje I Kester; Philip scheltens; Wiesje M van der Flier; Robert Veerhuis; Marinus A Blankenstein; Charlotte E Teunissen
Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2013;9(3):276-83.
2012: Maartje I Kester; Marleen J Koel-Simmelink; Peter G Scheffer; Philip scheltens; Charlotte E Teunissen; Harry Twaalfhoven; Jos W Twisk; Marinus A Blankenstein; Femke H Bouwman; Robert Veerhuis; Alie Schuitemaker; Wiesje M van der Flier
Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers.
Neurobiology of aging 2012;33(8):1591-8.
2012: Jeroen D C Goos; Philip scheltens; Charlotte E Teunissen; Frederik Barkhof; Marinus A Blankenstein; Robert Veerhuis; Nicolaas A Verwey; Wiesje M van der Flier
Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease.
Neurobiology of aging 2012;33(5):1011.e1-9.
2012: Chiara Mencarelli; Peter C Molenaar; Gerry A F Nicolaes; Harry W M Steinbusch; Robert Veerhuis; Gerard H Bode; Marc H De Baets; Mahesh Kulharia; Mario Losen; Pilar Martinez-Martinez
Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques.
The Journal of biological chemistry 2012;287(18):14897-911.
2012: Piet Eikelenboom; Annemieke J M Rozemuller; Erik van Exel; Willem A van Gool; Robert Veerhuis; Jeroen J M Hoozemans
Innate immunity and the etiology of late-onset Alzheimer's disease.
Neuro-degenerative diseases 2012;10(1-4):271-3.
2012: Sandra D Mulder; Marinus A Blankenstein; Robert Veerhuis; Henrietta M Nielsen
The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
Experimental neurology 2012;233(1):373-9.
2011: Ilona B Bruinsma; Anna Carrano; Mieke de Jager; Robert M W de Waal; Annemieke J M Rozemuller; Robert Veerhuis; Wilbert Boelens; Alexandra A M Versleijen; Marcel M Verbeek
Small heat shock proteins induce a cerebral inflammatory reaction.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011;31(33):11992-2000.
2011: Robert Veerhuis; Henrietta M Nielsen; Andrea J Tenner
Complement in the brain.
Molecular immunology 2011;48(14):1592-603.
2011: Piet Eikelenboom; Robert Veerhuis; E van Exel; Jeroen J M Hoozemans; Annemieke J M Rozemuller; Willem A van Gool
The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence.
Current Alzheimer research 2011;8(2):142-50.
2011: Robert Veerhuis
Histological and direct evidence for the role of complement in the neuroinflammation of AD.
Current Alzheimer research 2011;8(1):34-58.
2011: J J M Hoozemans; Robert Veerhuis; JM Rozemuller; Piet Eikelenboom
Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
CNS & neurological disorders drug targets 2011;10(1):57-67.
2010: Henrietta M Nielsen; Sandra D Mulder; Jeroen A M Beliën; René J P Musters; Piet Eikelenboom; Robert Veerhuis
Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins.
Glia 2010;58(10):1235-46.
2010: Ilona B Bruinsma; Micha M M Wilhelmus; Matthijs Kox; Robert Veerhuis; Robert M W de Waal; Marcel M Verbeek
Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death.
Brain research 2010;1315():169-80.
2010: Sandra D Mulder; Wiesje M van der Flier; Jan H Verheijen; Cees Mulder; Philip scheltens; Marinus A Blankenstein; C Erik Hack; Robert Veerhuis
BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
Journal of Alzheimer's disease : JAD 2010;20(1):253-60.
2010: Nicolaas Verwey; Maartje I Kester; Wiesje M van der Flier; Robert Veerhuis; Hans Berkhof; Harry Twaalfhoven; Marinus A Blankenstein; Philip Scheltens And; Yolande A L Pijnenburg
Additional value of CSF amyloid-beta 40 levels in the differentiation between FTLD and control subjects.
Journal of Alzheimer's disease : JAD 2010;20(2):445-52.
2010: Piet Eikelenboom; Erik van Exel; Jeroen J M Hoozemans; Robert Veerhuis; Annemieke J M Rozemuller; Willem A van Gool
Neuroinflammation - an early event in both the history and pathogenesis of Alzheimer's disease.
Neuro-degenerative diseases 2010;7(1-3):38-41.
2010: Marie Van Dijk; Jan van Bezu; Ankie Poutsma; Robert Veerhuis; Annemieke J Rozemuller; Wiep Scheper; Marinus A Blankenstein; Cees B Oudejans
The pre-eclampsia gene STOX1 controls a conserved pathway in placenta and brain upregulated in late-onset Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2010;19(2):673-9.
2010: Milan Fiala; Robert Veerhuis
Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease.
Experimental gerontology 2010;45(1):57-63.
2009: Alie Schuitemaker; Miranda G Dik; Robert Veerhuis; Philip scheltens; Niki S M Schoonenboom; C Erik Hack; Marinus A Blankenstein; Cees Jonker
Inflammatory markers in AD and MCI patients with different biomarker profiles.
Neurobiology of aging 2009;30(11):1885-9.
2009: Henrietta M Nielsen; Robert Veerhuis; Bo Holmqvist; Sabina Janciauskiene
Binding and uptake of A beta1-42 by primary human astrocytes in vitro.
Glia 2009;57(9):978-88.
2009: Micha M M Wilhelmus; Wilbert C Boelens; Matthijs Kox; Marion L C Maat-Schieman; Robert Veerhuis; Robert M W de Waal; Marcel M Verbeek
Small heat shock proteins associated with cerebral amyloid angiopathy of hereditary cerebral hemorrhage with amyloidosis (Dutch type) induce interleukin-6 secretion.
Neurobiology of aging 2009;30(2):229-40.
2008: Leendert A Trouw; Henrietta M Nielsen; Lennart Minthon; Elisabet Londos; Göran Landberg; Robert Veerhuis; Sabina Janciauskiene; Anna Blom
C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells.
Molecular immunology 2008;45(13):3649-60.
2008: Nicolaas A Verwey; Alie Schuitemaker; Wiesje M van der Flier; Sandra D Mulder; Cees Mulder; C Erik Hack; Philip scheltens; Marinus A Blankenstein; Robert Veerhuis
Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
Dementia and geriatric cognitive disorders 2008;26(6):522-7.
2008: Jeroen J M Hoozemans; JM Rozemuller; Elise S van Haastert; Robert Veerhuis; Piet Eikelenboom
Cyclooxygenase-1 and -2 in the different stages of Alzheimer's disease pathology.
Current pharmaceutical design 2008;14(14):1419-27.
2008: Piet Eikelenboom; Robert Veerhuis; Atoosa Familian; Jeroen J M Hoozemans; Willem A van Gool; Annemieke J M Rozemuller
Neuroinflammation in plaque and vascular beta-amyloid disorders: clinical and therapeutic implications.
Neuro-degenerative diseases 2008;5(3-4):190-3.
2008: Esther C W Breij; Bianca P Brink; Robert Veerhuis; Christa van den Berg; Rianka P M Vloet; Riqiang Yan; Christine D Dijkstra; Paul Van Der Valk; Lars Bö
Homogeneity of active demyelinating lesions in established multiple sclerosis.
Annals of neurology 2008;63(1):16-25.
2007: Micha M M Wilhelmus; Irene Otte-Höller; Jos J J van Triel; Robert Veerhuis; Marion L C Maat-Schieman; Guojun Bu; Robert M W de Waal; Marcel M Verbeek
Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells.
The American journal of pathology 2007;171(6):1989-99.
2007: Y A L Pijnenburg; S N M Schoonenboom; Pankaj D Mehta; Sangita P Mehta; Cees Mulder; Robert Veerhuis; Marinus A Blankenstein; Philip scheltens
Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration.
Journal of neurology, neurosurgery, and psychiatry 2007;78(7):735-7.
2007: Cees Mulder; Wiesje M van der Flier; Robert Veerhuis; Femke H Bouwman; Cornelis Jakobs; Nanda M Verhoeven; Frederik Barkhof; Philip scheltens; Marinus A Blankenstein
Association between vitamin B6 and white matter hyperintensities in patients with Alzheimer's disease not mediated by homocysteine metabolism.
Journal of the American Geriatrics Society 2007;55(6):956-8.
2007: Atoosa Familian; Piet Eikelenboom; Robert Veerhuis
Minocycline does not affect amyloid beta phagocytosis by human microglial cells.
Neuroscience letters 2007;416(1):87-91.
2006: Piet Eikelenboom; Robert Veerhuis; Wiep Scheper; Annemieke J M Rozemuller; Willem A van Gool; Jeroen J M Hoozemans
The significance of neuroinflammation in understanding Alzheimer's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(11):1685-95.
2006: Agata Copani; Jeroen J M Hoozemans; Filippo Caraci; marco calafiore; Elise S van Haastert; Robert Veerhuis; Annemieke J M Rozemuller; Eleonora Aronica; Maria Angela Sortino; Ferdinando Nicoletti
DNA polymerase-beta is expressed early in neurons of Alzheimer's disease brain and is loaded into DNA replication forks in neurons challenged with beta-amyloid.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(43):10949-57.
2006: Michael Hüll; Barbara Müksch; Ravi Shankar Akundi; Anne Waschbisch; Jeroen J M Hoozemans; Robert Veerhuis; Bernd L Fiebich
Amyloid beta peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes.
Neurochemistry international 2006;48(8):663-72.
2006: Jeroen J M Hoozemans; Jens Stieler; Elise S van Haastert; Robert Veerhuis; Annemieke J M Rozemuller; Frank Baas; Piet Eikelenboom; Thomas Arendt; Wiep Scheper
The unfolded protein response affects neuronal cell cycle protein expression: implications for Alzheimer's disease pathogenesis.
Experimental gerontology 2006;41(4):380-6.
2006: Jeroen J M Hoozemans; Robert Veerhuis; JM Rozemuller; Piet Eikelenboom
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2006;24(2-3):157-65.
2006: Anne Waschbisch; Bernd L Fiebich; Ravi Shankar Akundi; M Lienhard Schmitz; Jeroen J M Hoozemans; Eduardo Candelario-Jalil; Nina Virtainen; Robert Veerhuis; Helen Slawik; Juha Yrjänheikki; Michael Hüll
Interleukin-1 beta-induced expression of the prostaglandin E-receptor subtype EP3 in U373 astrocytoma cells depends on protein kinase C and nuclear factor-kappaB.
Journal of neurochemistry 2006;96(3):680-93.
2006: Atoosa Familian; Ronald S Boshuizen; Piet Eikelenboom; Robert Veerhuis
Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation.
Glia 2006;53(3):233-40.
2005: Jeroen J M Hoozemans; Elise S van Haastert; Robert Veerhuis; Thomas Arendt; Wiep Scheper; Piet Eikelenboom; Annemieke J M Rozemuller
Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease.
Journal of neuroinflammation 2005;2():27.
2005: Jeroen J M Hoozemans; Robert Veerhuis; Elise S van Haastert; JM Rozemuller; Frank Baas; Piet Eikelenboom; Wiep Scheper
The unfolded protein response is activated in Alzheimer's disease.
Acta neuropathologica 2005;110(2):165-72.
2005: Robert Veerhuis; Ronald S Boshuizen; Atoosa Familian
Amyloid associated proteins in Alzheimer's and prion disease.
Current drug targets. CNS and neurological disorders 2005;4(3):235-48.
2005: Robert Veerhuis; Ronald S Boshuizen; Michela Morbin; Giulia Mazzoleni; Jeroen J M Hoozemans; Johannes P M Langedijk; Fabrizio Tagliavini; Jan P M Langeveld; Piet Eikelenboom
Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q.
Neurobiology of disease 2005;19(1-2):273-82.
2005: Claudio Storini; Emanuela Rossi; Veronica Marrella; Maria Distaso; Robert Veerhuis; Carlo Vergani; Luigi Bergamaschini; Maria Grazia De Simoni
C1-inhibitor protects against brain ischemia-reperfusion injury via inhibition of cell recruitment and inflammation.
Neurobiology of disease 2005;19(1-2):10-7.
2005: Bianca P Brink; Robert Veerhuis; Esther C W Breij; Paul Van Der Valk; Christine D Dijkstra; Lars Bö
The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions.
Journal of neuropathology and experimental neurology 2005;64(2):147-55.
2004: Remco Nijmeijer; P A J Krijnen; J Assink; M A R Klaarenbeek; Wim Lagrand; Robert Veerhuis; Cees A Visser; C J L M Meijer; Hans W M Niessen; C Erik Hack
C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion.
European journal of clinical investigation 2004;34(12):803-10.
2004: Imrich Blasko; Michaela Stampfer-Kountchev; Peter Robatscher; Robert Veerhuis; Piet Eikelenboom; Beatrix Grubeck-Loebenstein
How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes.
Aging cell 2004;3(4):169-76.
2004: Clive Bate; Robert Veerhuis; Piet Eikelenboom; Alun Williams
Microglia kill amyloid-beta1-42 damaged neurons by a CD14-dependent process.
Neuroreport 2004;15(9):1427-30.
2004: Jeroen J M Hoozemans; Robert Veerhuis; Annemieke J M Rozemuller; Thomas Arendt; Piet Eikelenboom
Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex.
Neurobiology of disease 2004;15(3):492-9.
2003: Clive Bate; Robert Veerhuis; Piet Eikelenboom; Alun Williams
Neurones treated with cyclo-oxygenase-1 inhibitors are resistant to amyloid-beta1-42.
Neuroreport 2003;14(16):2099-103.
2003: Cees Mulder; Lars-Olof Wahlund; Tom Teerlink; M Blomberg; Robert Veerhuis; Gerard J van Kamp; Philip scheltens; Peter G Scheffer
Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(8):949-55.
2003: Jeroen J M Hoozemans; Robert Veerhuis; Annemieke J M Rozemuller; Piet Eikelenboom
Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease.
Current drug targets 2003;4(6):461-8.
2003: Robert Veerhuis; Mariëlle J Van Breemen; Jeroen M Hoozemans; Michela Morbin; Jamal Ouladhadj; Fabrizio Tagliavini; Piet Eikelenboom
Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Acta neuropathologica 2003;105(2):135-44.
2002: Cees Mulder; S N M Schoonenboom; Lars-Olof Wahlund; Philip scheltens; Gerard J van Kamp; Robert Veerhuis; C Erik Hack; M Blomberg; Ruud B H Schutgens; Piet Eikelenboom
CSF markers related to pathogenetic mechanisms in Alzheimer's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(12):1491-8.
2002: Piet Eikelenboom; Clive Bate; Willem A van Gool; Jeroen J M Hoozemans; JM Rozemuller; Robert Veerhuis; Alun Williams
Neuroinflammation in Alzheimer's disease and prion disease.
Glia 2002;40(2):232-9.
2002: Jeroen J M Hoozemans; Robert Veerhuis; Ingrid Janssen; Evert-Jan van Elk; Annemieke J M Rozemuller; Piet Eikelenboom
The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E(2) secretion by cultured human adult microglia: implications for Alzheimer's disease.
Brain research 2002;951(2):218-26.
2002: Jeroen J M Hoozemans; Martina K Brückner; Annemieke J M Rozemuller; Robert Veerhuis; Piet Eikelenboom; Thomas Arendt
Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex.
Journal of neuropathology and experimental neurology 2002;61(8):678-88.
2002: Jeroen J M Hoozemans; Robert Veerhuis; Annemieke J M Rozemuller; Piet Eikelenboom
The pathological cascade of Alzheimer's disease: the role of inflammation and its therapeutic implications.
Drugs of today (Barcelona, Spain : 1998) 2002;38(6):429-43.
2002: Robert Veerhuis; Jeroen J M Hoozemans; Ingrid Janssen; Ronald S Boshuizen; Jan P M Langeveld; Piet Eikelenboom
Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2.
Brain research 2002;925(2):195-203.
2001: Christianne J M De Groot; Sandra Hulshof; Jeroen J M Hoozemans; Robert Veerhuis
Establishment of microglial cell cultures derived from postmortem human adult brain tissue: immunophenotypical and functional characterization.
Microscopy research and technique 2001;54(1):34-9.
2001: Imrich Blasko; Gerhard Ransmayr; Robert Veerhuis; Piet Eikelenboom; Beatrix Grubeck-Loebenstein
Does IFNgamma play a role in neurodegeneration?
Journal of neuroimmunology 2001;116(1):1-4.
2001: Jeroen J M Hoozemans; Robert Veerhuis; Ingrid Janssen; Annemieke J M Rozemuller; Piet Eikelenboom
Interleukin-1beta induced cyclooxygenase 2 expression and prostaglandin E2 secretion by human neuroblastoma cells: implications for Alzheimer's disease.
Experimental gerontology 2001;36(3):559-70.
2001: Jeroen J M Hoozemans; Annemieke J M Rozemuller; Robert Veerhuis; Piet Eikelenboom
Immunological aspects of alzheimer's disease: therapeutic implications.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2001;15(5):325-37.
2001: Jeroen J M Hoozemans; Annemieke J M Rozemuller; Ingrid Janssen; Christianne J M De Groot; Robert Veerhuis; Piet Eikelenboom
Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain.
Acta neuropathologica 2001;101(1):2-8.
2000: Imrich Blasko; Robert Veerhuis; Michaela Stampfer-Kountchev; Maria Saurwein-Teissl; Piet Eikelenboom; Beatrix Grubeck-Loebenstein
Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes.
Neurobiology of disease 2000;7(6 Pt B):682-9.
2000: Christianne J M De Groot; Lisette Montagne; I Janssen; Rivka Ravid; Paul Van Der Valk; Robert Veerhuis
Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue.
Brain research. Brain research protocols 2000;5(1):85-94.
2000: Piet Eikelenboom; Annemieke J M Rozemuller; Jeroen J M Hoozemans; Robert Veerhuis; Willem A van Gool
Neuroinflammation and Alzheimer disease: clinical and therapeutic implications.
Alzheimer disease and associated disorders 2000;14 Suppl 1():S54-61.
1999: Robert Veerhuis; Ingrid Janssen; Christianne J M De Groot; Freek Van Muiswinkel; C Erik Hack; Piet Eikelenboom
Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Experimental neurology 1999;160(1):289-99.
1999: Piet Eikelenboom; Robert Veerhuis
The importance of inflammatory mechanisms for the development of Alzheimer's disease.
Experimental gerontology 1999;34(3):453-61.
1998: Marcel M Verbeek; Irene Otte-Höller; Robert Veerhuis; Dirk J Ruiter; Robert M W de Waal
Distribution of A beta-associated proteins in cerebrovascular amyloid of Alzheimer's disease.
Acta neuropathologica 1998;96(6):628-36.
1998: Robert Veerhuis; Ingrid Janssen; Jeroen J M Hoozemans; Christianne J M De Groot; C Erik Hack; Piet Eikelenboom
Complement C1-inhibitor expression in Alzheimer's disease.
Acta neuropathologica 1998;96(3):287-96.
1997: M A Blom; M G van Twillert; S C de Vries; F Engels; Caleb E Finch; Robert Veerhuis; Piet Eikelenboom
NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2.
Brain research 1997;777(1-2):210-8.
1996: Piet Eikelenboom; Robert Veerhuis
The role of complement and activated microglia in the pathogenesis of Alzheimer's disease.
Neurobiology of aging 1996;17(5):673-80.
1996: Freek Van Muiswinkel; Robert Veerhuis; Piet Eikelenboom
Amyloid beta protein primes cultured rat microglial cells for an enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity.
Journal of neurochemistry 1996;66(6):2468-76.
1996: Robert Veerhuis; Ingrid Janssen; C Erik Hack; Piet Eikelenboom
Early complement components in Alzheimer's disease brains.
Acta neuropathologica 1996;91(1):53-60.
1995: S S Zhan; Robert Veerhuis; Wouter Kamphorst; Piet Eikelenboom
Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1995;4(3):291-7.
1995: Robert Veerhuis; P van der Valk; Ingrid Janssen; S S Zhan; William E Van Nostrand; Piet Eikelenboom
Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.
Virchows Archiv : an international journal of pathology 1995;426(6):603-10.